Latest Nature Medicine Stories
An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection.
Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes.
Human colon stem cells have been identified and grown in a lab-plate for the first time.
A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice.
Scientists at the Albert Einstein College of Medicine reported on Sunday that a vaccine they developed for tuberculosis had shown promising results during early laboratory testing in mice.
Reconnecting severed blood vessels is mostly done the same way today — with sutures — as it was 100 years ago, when the French surgeon Alexis Carrel won a Nobel Prize for advancing the technique.
Cancer scientists have long debated whether all cells within a tumour are equal or whether some cancer cells are more potent - a question that has been highly investigated in experimental models in the last decade.
Obesity is growing at alarming rates worldwide, and the biggest culprit is overeating.
Researchers have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection.
Researchers may have discovered an impressive new weapon in the struggle against hospital-acquired bacterial infections.
Nature Medicine is a peer-reviewed academic journal established in 1995 and published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. As with other Nature journals, this periodical has no external Editorial Board, with editorial decisions being made by an in-house team. Nature Medicine publishes research articles, reviews, news and commentary pieces. Topics include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. Research...